Grace Therapeutics, Inc.
SEC CIK 1444192 · GRCE · last insider filing 2026-01-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Davis A Brian | Director | filed 2023 - 2026 |
| Neugeboren Edward | Director | filed 2023 - 2026 |
| Kavuru Vimal | Director | filed 2021 - 2026 |
| Kottayil George | Director · COO, US | filed 2021 - 2026 |
| Kohli Prashant | Director · Chief Executive Officer | filed 2022 - 2025 |
| Olds Donald | Director | filed 2020 - 2023 |
| Derby Michael | Director | filed 2022 - 2023 |
| Canan John | Director | filed 2017 - 2022 |
| D'Alvise Janelle | Director · PRESIDENT & CEO | filed 2020 - 2022 |
| Carter Roderick Noel | Director | filed 2020 - 2021 |
| Haseltine William A | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Macdonald R. Loch | Chief Medical Officer | filed 2023 - 2025 |
| Delaversano Robert J | Vice President, Finance | filed 2024 - 2025 |
| D'Andrea Carrie | VP Program Management | filed 2023 - 2025 |
| Kumar Amresh | VP Program Management | filed 2023 - 2025 |
| Lemieux Pierre | COO, Canada & CSO | filed 2020 - 2022 |
| Ford Brian D. | CHIEF FINANCIAL OFFICER | filed 2020 - 2022 |
| Groch Brian J. | CHIEF COMMERCIAL OFFICER | filed 2020 - 2020 |
| Boily Jean-Francois | VICE-PRESIDENT, FINANCE | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.